Skip to main content
. 2013 Jul 15;6(8):1493–1504.

Figure 7.

Figure 7

Potential mechanism by which NSCLC cells with wt EGFR display resistance to erlotinib. The up-regulation of ErbB ligands (TGF-α, EREG and NRG4) activates EGFR. Activation of RAF1-MEK1-ERK and PKC/SNAI-AKT up-regulates the downstream signaling and hence confers NSCLC cells harboring wt EGFR resistance to erlotinib. The pink molecules represent that its mRNA expression is up-regulated. The orange molecules mean that it is activated.